Blog Profile / The Health Care Blog

Filed Under:Industries / Medical
Posts on Regator:1630
Posts / Week:3.2
Archived Since:March 5, 2008

Blog Post Archive

Amazon (Probably) Is About to Lose Out

By ROGER COLLIER Dear Jeff Bezos: It looked like a great idea when you started to build a team of healthcare specialists back in the summer. Despite — or perhaps because of — endless attempts to control costs and improve quality, American healthcare remains (in the words of a recent THCB post) “a version of

What investors are saying about the state of digital health

Health 2.0 caught up with some of our favorite investors who have a strong pulse on what’s happening in digital health care both past and present. We talked about company evaluation, unmet needs in health care, and their biggest surprises yet. Read the full interview featuring Lisa Suennen of GE Ventures, Bryan Roberts of Venrock, Rich Roth ofDignity

Health Care Needs Its Rosa Parks Moment

BY SHANNON BROWNLEE On Wednesday, October 25, 2017 I was at the inaugural Society for Participatory Medicine conference. It was a fantastic day and the ending keynote was the superb Shannon Brownlee. It was great to catch up with her and I’m grateful that she agreed to let THCB publish her speech. Settle back with

Purging Healthcare of Unnatural Acts

BY UWE REINHARDT In tribute to Uwe we are re-running this instant classic from THCB’s archives. Originally published on Jan 31, 2017. Everyone knows (or should know) that forcing a commercial health insurer to write for an individual a health insurance policy at a premium that falls short of the insurer’s best ex ante estimate

The Great American Hypertension Epidemic of 2017

By MICHEL ACCAD, MD On November 15, 2017, an epidemic of hypertension broke out and could rapidly affect tens of millions of Americans.  The epicenter of the outbreak was traced back to the meeting of the American Heart Association in Anaheim, CA. The pathogen was released in a special 488-page document labeled “Hypertension Guidelines.”  The

What Baseball Can Teach Doctors

By MICHAEL MILLENSON Baseball, like medicine, is deeply imbued with a sense of tradition, and no team more so than the New York Yankees, disdainful of innovations like placing players’ names on the backs of their jerseys and resistant to eroding strict standards related to haircuts and beards. It’s why doctors and patients alike should

The New Health Care Experience For Consumers

By HEALTH 2.o                                     SPONSORED CONTENT We are human and we need health care. These are universal truths. Here’s another one – we are consumers. Consumers who happen to be in a constant state of adapting to new health care protocols. The advent of value-based care over fee-for-service has also seen an emergence


By THE EDITORS The Four Things Keeping Hospital CEOs Awake at Night This Year (Hint: Donald Trump Isn’t One of Them) BY PAUL KECKLEY Valuing Value-Based Payment By ANISH KOKA, MD Dear Humans, Diverse Social Networks Are The Answer  By MARTY SAMUELS, MD Why Smart Pill Bottles & Financial Rewards Don’t Improve Medication Adherence By

Remembering Uwe

By JEFF GOLDSMITH The healthcare world learned with great sadness this week of the passing of our friend, Uwe Reinhardt. I met Uwe in 1982 at the Federation of American Hospitals meeting in Las Vegas. Uwe opened the meeting by apologizing, in his disarming German accent, for not being his usual sharp self. He had,

Trump’s New Man at HHS

By STEVE FINDLAY President Trump’s nominee to be the next HHS Secretary—Alex Azar—has a sparkling resume and by most accounts is a practical, accomplished and solid choice to lead the agency and the federal government’s health programs for at least the next 3 years. He served as HHS Deputy Secretary under George W. Bush. But

A Brief History of Price Controls by Annoyed Republican Administrations

By UWE REINHARDT Although, unlike most other nations, the U.S. has only two parties worth the name, their professed doctrines compared with their actions strikes me as more confusing than the well-known Slutsky Decomposition which, as everyone knows, can be derived simply from a straightforward application of Kramer’s rule to a matrix of second partial

Uwe Reinhardt 1937-2017

Uwe Reinhardt, Princeton economist and one of the best known and best loved personalities in the health policy world died today. I join the rest of the health policy community in mourning the passing of the master explainer and wit that Uwe was. But I also remember a small act of his kindness. The first

What Would a Disrupted Health Care Field Look Like?

By ANDY ORAM Clayton Christensen, the famous economist who popularized ideas of innovation and disruption, showed up at the recent Connected Health conference in Boston. Although billed as a panelist, he turned up without warning as a guest in a keynote and posed the same question I asked in an article back in July: “The

The Next Tech Wave To Impact Personalized Health

The Technology For Precision Health Summit is just around the corner, and it’s the place to discover new digital platforms that will improve the patient experience, and access a deeper insight into the data behind key decisions for treatment and for maintaining health. Show More Summary

Why Hospitals Are Losing Serious Money And What That Means For Your Future

By ROBERT PEARL, MD A strange thing happened last year in some the nation’s most established hospitals and health systems. Hundreds of millions of dollars in income suddenly disappeared. This article examines the economic struggles of inpatient facilities, the even harsher realities in front of them, and why hospitals are likely to aggravate, not address,

Practicing Medicine While Black

By KIP SULLIVAN, JD The managed care movement thrives on misleading words and phrases. Perhaps the worst example is the incessant use of the word “quality” to characterize a problem that has multiple causes, only one of which might be inferior physician or hospital quality. [1] To illustrate with a non-medical analogy, no one would

12 Seconds of Placebo – An Outsider’s View of ORBITA

By, SAURABH JHA MD   The reactions of physicians to ORBITA, a blinded, randomized controlled trial (RCT) from Britain, with a sham arm, comparing percutaneous coronary intervention (PCI) to placebo, in patients with stable angina, are as fascinating as the cardiac cycle. There were murmurs, kicks, and pulsating jugulars. Though many claimed to be surprised,

The DNA Tool That You Must See

Most people have no way of accessing DNA-powered insights about themselves, and no way to store and use their genome in ways that they control. Technology for Precision Health Summit demoer Helix solves that by providing the world’s first...Show More Summary

Right to Know: Why the FDA Should Not Be Cut Out of Expanded Access Requests

By CHAPMAN, KLEIN and McFADYEN Over the past three years, the libertarian Goldwater Institute–led right to try (RTT) movement has had wind in its sails, propelling the passage of RTT laws in 38 states and counting. The movement, which aims to cut the FDA out of the process by which patients with serious or immediately

The Dunning-Kruger Effect, Or the Real Reason Why the Guys Trying to “Fix” Health Care Are Driving You Crazy

By HANS DUVEFELT, MD “The fool doth think he is wise, but the wise man knows himself to be a fool.” – Willam Shakespeare I learned about the Dunning-Kruger effect at a medical conference recently. It certainly seems to apply in medicine. So often, a novice thinks he or she has mastered a new skill or achieved

Copyright © 2015 Regator, LLC